nach oben

Lung

Erschienen in:

01.02.2013

Obstructive Sleep Apnea Syndrome: Blood Viscosity, Blood Coagulation Abnormalities, and Early Atherosclerosis

verfasst von: Domenico Maurizio Toraldo, Francesco Peverini, Michele De Benedetto, Francesco De Nuccio

Erschienen in: Lung | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Obstructive sleep apnea syndrome (OSAS) is an independent risk factor for atherosclerosis and arterial thrombosis, which are associated with high cardiovascular (CV) morbidity and mortality. In studies performed in clinical populations with elevated CV event risk profiles, the occurrence of moderate to severe OSAS was very often accompanied by a worsened vascular function and increased prevalence of structural abnormalities. Recent investigations of atherosclerosis in OSAS have focused on thrombotic tendency and blood viscosity, providing new insight into mechanisms of the disease. Despite that knowledge about the mechanisms of development of CV disease in patients with OSAS is still incomplete, observations confirm a relationship between sleep-disordered breathing and the rheological properties (flow properties) of blood. While platelet dysfunction and hypercoagulability (PDMPs, PaI-1, and SF) play important roles in the pathogenesis of vascular disease, there are limited studies on the potential role of blood viscosity in the development of vascular disease in OSAS.

Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235PubMedCrossRef

Marin JM, Carrizo SJ, Vicente E, Agusti AG (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea–hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046–1053PubMed

Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A et al (2008) Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council On Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). Circulation 118:1080–1111PubMedCrossRef

Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Tanaka A, Oda N, Okada S, Ohta S, Naito H, Adachi M (2005) Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172:625–630PubMedCrossRef

Ip MS, Tse HF, Lam B, Tsang KW, Lam WK (2004) Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 169:348–353PubMedCrossRef

Buchner NJ, Sanner BM, Borgel J, Rump LC (2007) Continuous positive airway pressure treatment of mild to moderate obstructive sleep apnea reduces cardiovascular risk. Am J Respir Crit Care Med 176:1274–1280PubMedCrossRef

Sorajja D, Gami AS, Somers VK, Behrenbeck TR, Garcia-Touchard A, Lopez-Jimenez F (2008) Independent association between obstructive sleep apnea and subclinical coronary artery disease. Chest 133:927–929PubMedCrossRef

Baskurt OK, Hardeman MR, Rampling MW, Meiselman HJ (2007) Handbook of Hemorheology and Hemodynamics. IOS, Lansdale

Holsworth RE, Wright JV (2012) Blood viscosity: the unifying parameter in cardiovascular disease risk. Holist Prim Ore 13:1

10.

Rafnsson S, Deary IJ, Whiteman MC, Rumley A, Lowe GD, Fowkes FG (2010) Haemorheological predictors of cognitive decline: the Edinburgh Artery Study. Age Ageing 39:217–222PubMedCrossRef

11.

Ciuffetti G, Schillaci G, Lombardini R, Pirro M, Vaudo G, Mannarino E (2005) Prognostic impact of low-shear whole blood viscosity in hypertensive men. Eur J Clin Invest 35:93–98PubMedCrossRef

12.

Housley E, Cawood EH, Macintyre CC, Ruckley CV, Prescott RJ (1991) Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20:384–392PubMedCrossRef

13.

Lowe GDO, Wood DA, Douglas JT, Riemersma RA, Mcintyre CCA, Takase T, Tuddenham EGD, Forbes CD, Elton RA, Oliver MF (1991) Relationships of plasma viscosity, coagulation and fibrinolysis to coronary risk factors and angina. Thromb Haemost 65:339–343PubMed

14.

Meade TW, North WR, Chakrabarti R, Stirling Y, Haines AP, Thompson SG, Brozovié M (1980) Haemostatic function and cardiovascular death: early results of a prospective study. Lancet 1:1050–1054PubMedCrossRef

15.

Lee AJ, Smith WC, Lowe GD, Tunstall-Pedoe H (1990) Plasma fibrinogen and coronary risk factors: The Scottish Heart Health Study. J Clin Epidemiol 43:913–919PubMedCrossRef

16.

Dikmenoğlu N, Ciftçi B, Ileri E, Güven SF, Seringeç N, Aksoy Y, Ercil D (2006) Erythrocyte deformability, plasma viscosity and oxidative status in patients with severe obstructive sleep apnea syndrome. Sleep Med 7:255–261PubMedCrossRef

17.

Landgraf H (1999) Correlation between plasma viscosity and tissue oxygen tension. Clin Hemorheol Microcirc 20:37–40PubMed

18.

Parish JM, Somers VK (2004) Obstructive sleep apnea and cardiovascular disease. Mayo Clin Proc 79:1036–1046PubMedCrossRef

19.

Steiner S, Jax T, Evers S, Hennersdorf M, Schwalen A, Strauer BE (2005) Altered blood rheology in obstructive sleep apnea as a mediator of cardiovascular risk. Cardiology 104:92–96PubMedCrossRef

20.

Tazbirek M, Slowińska L, Skoczyński S, Pierzchała W (2009) Short-term continuous positive airway pressure therapy reverses the pathological influence of obstructive sleep apnea on blood rheology parameters. Clin Hemorheol Microcirc 41:241–249PubMed

21.

Chin K, Ohi M, Kita H, Noguchi T, Otsuka N, Tsuboi T, Mishima M, Kuno K (1996) Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. Am J Respir Crit Care Med 153:1972–1976PubMed

22.

Nobili L, Schiavi G, Bozano E, De Carli F, Ferrillo F, Nobili F (2000) Morning increase of whole blood viscosity in obstructive sleep apnea syndrome. Clin Hemorheol Microcirc 22:21–27PubMed

23.

Reinhart WH, Oswald J, Walter R, Kuhn M (2002) Blood viscosity and platelet function in patients with obstructive sleep apnea syndrome treated with nasal continuous positive airway pressure. Clin Hemorheol Microcirc 27:201–207PubMed

24.

Zhang X, Yin K, Wang H, Su M, Yang Y (2003) Effect of continuous positive airway pressure treatment on elderly Chinese patients with obstructive sleep apnea in the prothrombotic state. Chin Med J (Engl) 116:1426–1428

25.

Lowe GD (1992) Blood viscosity, lipoproteins and cardiovascular risk. Circulation 85:2329–2331PubMedCrossRef

26.

De Simone G, Devereux RB, Chien S, Alderman MH, Atlas SA, Larach JH (1990) Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation 81:107–117PubMedCrossRef

27.

Fanari P, Somazzi R, Nasrawi F, Ticozzelli P, Grugni G, Agosti R, Longhini E (1993) Haemorheological changes in obese adolescents after short-term diet. Int J Obes Relat Metab Disord 17:487–494PubMed

28.

Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J (1994) Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 14:54–59PubMedCrossRef

29.

Wessendorf TE, Thilmann AF, Wang YM, Schreiber A, Konietzko N, Teschler H (2000) Fibrinogen levels and obstructive sleep apnea in ischemic stroke. Am J Respir Crit Care Med 162:2039–2042PubMed

30.

McNicholas WT, Bonsignore, The Management Committee of EU COST ACTION B26 (2007) Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanism and research priorities. Eur Respir J 29:156–178PubMedCrossRef

31.

Lavie L (2003) Obstructive sleep apnoea syndrome—an oxidative stress disorder. Sleep Med Rev 7:35–51PubMedCrossRef

32.

Nieto FJ, Herrington DM, Redline S, Benjamin EJ, Robbins JA (2004) Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 169:354–360PubMedCrossRef

33.

von Känel R, Dimsdale JE (2003) Hemostatic alterations in patients with obstructive sleep apnea and the implications for cardiovascular disease. Chest 124:1956–1967CrossRef

34.

Mackman N (2009) On the trail of microparticles. Circ Res 104:925–927PubMedCrossRef

35.

Nomura S (2001) Function and clinical significance of platelet-derived microparticles. Int J Hematol 74:397–404PubMedCrossRef

36.

Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, Ataullakhanov FI (2007) Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 97(3):425–434PubMed

37.

Gilbert GE, Sims PJ, Wiedmer T, Furie B, Furie BC, Shattil SJ (1991) Platelet-derived microparticles express high affinity receptors for factor VIII. J Biol Chem 266:17261–17268PubMed

38.

Dougu N, Takashima S, Sasahara E, Taguchi Y, Toyoda S, Hirai T, Nozawa T, Tanaka K, Inoue H (2011) Predictors of poor outcome in patients with acute cerebral infarction. J Clin Neurol 7(4):197–202PubMedCrossRef

39.

Shitrit D, Peled N, Shitrit AB, Meidan S, Bendayan D, Sahar G, Kramer MR (2005) An association between oxygen desaturation and D-dimer in patients with obstructive sleep apnea syndrome. Thromb Haemost 94:544–547PubMed

40.

von Kanel R, Loredo JS, Powell FL, Adler KA, Dimsdale JE (2005) Short-term isocapnic hypoxia and coagulation activation in patients with sleep apnea. Clin Hemorheol Microcirc 33:369–377

41.

Kaditis AG, Alexopoulos EI, Kalampouka E, Kostadima E, Angelopoulos N, Germenis A, Zintzaras E, Gourgoulianis K (2004) Morning levels of fibrinogen in children with sleep disordered breathing. Eur Respir J 24:790–797PubMedCrossRef

42.

Shimizu M, Kamio K, Haida M, Ono Y, Miyachi H, Yamamoto M, Shinohara Y, Ando Y (2002) Platelet activation in patients with obstructive sleep apnea syndrome and effects of nasal-continuous positive airway pressure. Tokai J Exp Clin Med 27:107–112PubMed

43.

Hui DS, Ko FW, Fok JP, Chan MC, Li TS, Tomlinson B, Cheng G (2004) The effects of nasal continuous positive airway pressure on platelet activation in obstructive sleep apnea syndrome. Chest 125:1768–1775PubMedCrossRef

44.

Geiser T, Buck F, Meyer BJ, Bassetti C, Haeberli A, Gugger M (2002) In vivo platelet activation is increased during sleep in patients with obstructive sleep apnea syndrome. Respiration 69:229–234PubMedCrossRef

45.

Siegal T, Seligsohn U, Aghai E, Modan M (1978) Clinical and laboratory aspects of disseminated intravascular coagulation (DIC): a study of 118 cases. Thromb Haemost 39:122–134PubMed

46.

Plaikner M, Peer A, Falkensammer G, Schmidauer C, Pechlaner C, Griesmacher A, Pachinger O, Mair J (2009) Lack of association of soluble CD40 ligand with the presence of acute myocardial infarction or ischemic stroke in the emergency department. Clin Chem 55(1):175–178PubMedCrossRef

47.

Jacobin-Valat MJ, Deramchia K, Mornet S, Hagemeyer CE, Bonetto S, Robert R, Biran M, Massot P, Miraux S, Sanchez S, Bouzier-Sore AK, Franconi JM, Duguet E, Clofent-Sanchez G (2010) MRI of inducible P-selectin expression in human activated platelets involved in the early stages of atherosclerosis. NMR Biomed 24:413–424PubMed

48.

Robinson GV, Pepperell JC, Segal HC, Davies RJ, Stradling JR (2004) Circulating cardiovascular risk factors in obstructive sleep apnea: data from randomised controlled trial. Thorax 59:777–782PubMedCrossRef

49.

Ryan S, Taylor CT, McNicholas WT (2009) Systemic inflammation: a key factor in the pathogenesis of cardiovascular complications in obstructive sleep apnea syndrome? Thorax 64:631–636PubMed

50.

Maruyama K, Morishita E, Sekiya A, Omote M, Kadono T, Asakura H, Hashimoto M, Kobayashi M, Nakatsumi Y, Takada S, Ohtake S (2012) Plasma levels of platelet-derived microparticles in patients with obstructive sleep apnea. J Atheroscler Thromb 19(1):98–104PubMedCrossRef

51.

Arnulf I, Merino-Andreu M, Perrier A, Birolleau S, Similowski T, Derenne JP (2002) Obstructive sleep apnea and venous thromboembolism. JAMA 287:2655–2656PubMedCrossRef

52.

Ambrosetti M, Lucioni A, Ageno W, Conti S, Neri M (2004) Is venous thromboembolism more frequent in patients with obstructive sleep apnea syndrome? J Thromb Haemost 2:1858–1860PubMedCrossRef

53.

Epstein MD, Segal LN, Ibrahim SM, Friedman N, Bustami R (2010) Snoring and the risk of obstructive sleep apnea in patients with pulmonary embolism. Sleep 33:1069–1074PubMed

54.

Haus E (1996) Biologic rhythms in hematology. Patol Biol (Paris) 44:618–630

55.

Lamont EW, James FO, Boivin DB, Cermakian N (2007) From circadian clock gene expression to pathologies. Sleep Med 8:547–556PubMedCrossRef

56.

Barceló A, Piérola J, de la Peña M, Esquinas C, Sanchez-de la Torre M, Ayllón O, Alonso A, Agusti AG, Barbè F (2011) Day-night variations in endothelial dysfunction markers and haemostatic factors in sleep apnoea. Eur Respir J 39:913–918PubMedCrossRef

Titel: Obstructive Sleep Apnea Syndrome: Blood Viscosity, Blood Coagulation Abnormalities, and Early Atherosclerosis
verfasst von: Domenico Maurizio Toraldo
Francesco Peverini
Michele De Benedetto
Francesco De Nuccio
Publikationsdatum: 01.02.2013
Verlag: Springer-Verlag
Erschienen in: Lung / Ausgabe 1/2013
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI: https://doi.org/10.1007/s00408-012-9427-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

23.04.2024 | Ablationstherapie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Obstructive Sleep Apnea Syndrome: Blood Viscosity, Blood Coagulation Abnormalities, and Early Atherosclerosis

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Hinter dieser Appendizitis steckte ein Erreger

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2013

Linear Probe Endobronchial Ultrasound Bronchoscopy with Guided Transbronchial Needle Aspiration (EBUS–TBNA) in the Evaluation of Mediastinal and Hilar Pathology: Introducing the Procedure to a Teaching Institution

Infectious Diseases Causing Diffuse Alveolar Hemorrhage in Immunocompetent Patients: A State-of-the-Art Review

Is There an Added Value of Cardiopulmonary Exercise Testing in Sarcoidosis Patients?

Diffuse Alveolar Hemorrhage in Coumarin Users: A Fibrosing Interstitial Pneumonia Trigger?

Identification of Subtypes of Refractory Asthma in Korean Patients by Cluster Analysis

Clinical Usefulness of the Two-Question Assessment Tool for Depressive Symptoms in Japanese Patients with Chronic Obstructive Pulmonary Disease

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

Europäische Ernährungsgewohnheiten: Das sind die häufigsten Fehler

Hinter dieser Appendizitis steckte ein Erreger

Demenzkranke durch Antipsychotika vielfach gefährdet

Update Innere Medizin